Australia Court Enjoins Smith & Nephew Until KCI Patent Suit Tried
This article was originally published in PharmAsia News
An Australian federal court issued an injunction against U.K.-based Smith & Nephew in a patent dispute with U.S.-based Kinetic Concepts over negative-pressure wound therapy foam-dressing kits. The injunction was issued as the dispute was scheduled to go to trial sometime next year. KCI accuses Smith & Nephew of infringing on Australia-filed device patents owned by Wake Forest University of the United States and licensed to KCI as Vacuum Assisted Closure. Smith & Nephew denied it was infringing on the school's patents. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.